Don't Just Read the News, Understand It.

Browser Extension

Sunday, June 1, 2025

US Edition

Subscribe Login

Champions League

Paris Saint-Germain

Israel-Hamas Conflict

Natural Disasters

Artificial Intelligence

New York Knicks

Daily-remedy.com image

News from Daily-remedy.com

Topics Most Covered by daily-remedy.com

Artificial Intelligence

Artificial Intelligence

Sources Covering Similar Topics

The Epoch Times

Suggest a source

Looking for a source we don't already have? Suggest one here.

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Champions League Paris Saint-Germain Baseball NCAA Israel-Hamas Conflict

Trending in U.S.Israel-Hamas Conflict Baseball NCAA New York Knicks Home Run

Trending in U.K.Israel-Hamas Conflict Manchester United Premier League UK Economy UK Politics

Trending Topics

Champions League Paris Saint-Germain Baseball NCAA Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from Daily-remedy.com

See all of Daily-remedy.com news coverage in one place. Discover how Daily-remedy.com’s media bias informs their coverage and compare with thousands of other news outlets.

Ground News has come across 88 headlines reported on by Daily-remedy.com during the past 3 months.

Daily-remedy.com’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Is Daily-remedy.com credible or reliable? Our Factuality score answers both of those questions. When it comes to Daily-remedy.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

See all of Daily-remedy.com news coverage in one place. Discover how Daily-remedy.com’s media bias informs their coverage and compare with thousands of other news outlets. Ground News has come across 88 headlines reported on by Daily-remedy.com during the past 3 months.

Daily-remedy.com’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check. Is Daily-remedy.com credible or reliable? Our Factuality score answers both of those questions. When it comes to Daily-remedy.com, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Daily-remedy.com

Where is Daily-remedy.com located?Daily-remedy.com's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Breaking News Topics Related to Daily-remedy.com

Health

Google

Artificial Intelligence

Vaccines

California, United States

United States

Healthcare

Medical

Similar News Topics

MedCity News

The Epoch Times

FOX13news

Endpoints News

Benzinga

Top Daily-remedy.com News

FDA Approves Nucala for Chronic Obstructive Pulmonary Disease

FDA · United States

FDA Approves Nucala for Chronic Obstructive Pulmonary Disease

43% Center coverage: 35 sources

FRIDAY, May 23, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD).See the Story

GSB Student Takes a New Approach to Treating Eating Disorders

United Nations · United States

GSB Student Takes a New Approach to Treating Eating Disorders

100% Left coverage: 1 sources

Content warning: This article contains references to eating disorders and suicide. Mehek Mohan MBA ’25 built Kahani, an app designed to treat eating disorders, because people still aren’t paying enough attention to one of psychiatry’s deadliest issues, she said. “Not enough people care about this space, [yet] statistically, everyone knows someone with an eating disorder,” Mohan, who studied molecular and cellular biology at Berkeley and then led…See the Story

Seeking Therapy From an AI Bot? Think Again

Artificial Intelligence · India

Seeking Therapy From an AI Bot? Think Again

The world today is becoming increasingly connected, yet paradoxically lonelier than ever. Alongside mental health concerns, this has emerged as one of the most pressing issues of our time. With the advent of conversational AI, people can now engage in dialogue without needing another human present. This increased accessibility has fueled the global use of AI chatbots, often leading to emotional attachment and, in some cases, growing social deta…See the Story

Signals and Silos: Telehealth’s Decentralized Revolution and the Fragmentation of Patient Trust

Signals and Silos: Telehealth’s Decentralized Revolution and the Fragmentation of Patient Trust

The future of healthcare may no longer be in the clinic—it may be in the connection. In just five years, telehealth has evolved from a peripheral convenience to a structural pillar of modern medicine. Driven first by pandemic necessity and now by economic logic, the shift has been swift, strategic, and largely successful. Virtual appointments, asynchronous check-ins, remote monitoring—what was once a contingency has become clinical routine. But …San Francisco, California · San Francisco Read Article

Bought and Billed: How Healthcare Mergers Are Undermining the Meaning of Care

Bought and Billed: How Healthcare Mergers Are Undermining the Meaning of Care

Hospitals are being bought faster than patients can heal. In 2025, the healthcare industry is in the throes of another consolidation wave. Big names are getting bigger. Regional systems are becoming national. Private equity is no longer lurking at the margins—it’s at the center of hospital boardrooms. Each acquisition, merger, or strategic partnership is marketed as a pathway to operational efficiency and better patient outcomes. But beneath tha…United States · United States Read Article

More Than a Pop Star Problem: Miley Cyrus, Ovarian Cysts, and the Silence Around Gynecological Pain

More Than a Pop Star Problem: Miley Cyrus, Ovarian Cysts, and the Silence Around Gynecological Pain

It wasn’t a red carpet moment, but it made headlines just the same. In a candid interview, pop icon Miley Cyrus revealed she had experienced an “excruciating” ovarian cyst rupture—an intensely painful, often underreported gynecological event that affects millions of women but rarely commands serious attention. Her admission, both vulnerable and unfiltered, struck a nerve: not just because of who she is, but because of how rarely public figures s…Miley Cyrus · United States Read Article

'Tampa Bay Connections' aimed at combating loneliness

'Tampa Bay Connections' aimed at combating loneliness

100% Center coverage: 1 sources

Three Tampa Bay area mayors are coming together in support of a new initiative aimed at reducing loneliness – something organizers call a "growing public health crisis."Smoking See the Story

Clot Watch: How AI Is Rewriting the Rules of Cardiovascular Medicine

Clot Watch: How AI Is Rewriting the Rules of Cardiovascular Medicine

A clot moves in silence—until it kills. That brutal, biological truth has haunted emergency rooms for decades. Strokes, heart attacks, pulmonary embolisms—these events often strike without warning, leaving little time for intervention. The human body gives few outward signs of the tiny, deadly formations that can trigger these catastrophes. But a breakthrough from the University of Tokyo may change that equation entirely, offering a glimpse into…Artificial Intelligence · Spain See the Story

AI vs. the Silent Killer: How Artificial Intelligence Is Rewriting the Rules of Pancreatic Cancer Diagnosis

AI vs. the Silent Killer: How Artificial Intelligence Is Rewriting the Rules of Pancreatic Cancer Diagnosis

It begins, as it so often does, in silence. Pancreatic cancer—one of the most lethal malignancies known to modern medicine—lurks without symptoms until its grip is near inescapable. For decades, clinicians have relied on a medley of clinical suspicion, imaging, and vague symptomatology to flag its presence. But in this realm of uncertainty, artificial intelligence may now be offering something medicine has long sought: clarity. In a study making…Artificial Intelligence · United States Read Article

Muted by the Algorithm: The Unseen Censorship of Women’s Health

Muted by the Algorithm: The Unseen Censorship of Women’s Health

A pad. A period. A hot flash. These everyday realities for half the global population remain shadowed in euphemism and silence—especially online. Now, as a growing body of evidence reveals, that silence may not be coincidental. It may be programmed. A UK-based study published in BMJ Global Health recently found that women’s health content is disproportionately censored by social media platforms compared to men’s health content. Posts about menst…United Kingdom · United Kingdom Read Article

Selling the Cure: The Surge of Direct-to-Consumer Drug Ads and the Medicalization of Everyday Life

Selling the Cure: The Surge of Direct-to-Consumer Drug Ads and the Medicalization of Everyday Life

The most influential doctor in America might be your television. In the first quarter of 2025, direct-to-consumer (DTC) pharmaceutical advertising spending reached a historic peak, with a double-digit percentage increase over the same period last year, according to Kantar Media and IQVIA. The surge was driven primarily by the runaway popularity of GLP-1 receptor agonists—injectable medications originally approved for diabetes but now best known …United States · United States Read Article